5 studies found for: c-myc | Open Studies | diffuse large b-cell lymphoma OR DLBCL
Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma
DA-EPOCH-Rituximab/Metformin (RM) for Double Hit Lymphoma
A Phase I Study of Alisertib + R-EPOCH for Treatment of Myc-Positive Aggressive B-cell Lymphomas
|4||Not yet recruiting||
Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma
An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies
† Study has passed its completion date and status has not been verified in more than two years.